Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
CRSP:NASDAQ
Crispr Therapeutics AG
US$51.63
-1.36%
(-0.71) 1D
US$51.42
-0.41% (-0.21)
After hours
Closed: 1 મે, 04:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRSP...
ખોલો
US$51.59
High
US$52.56
Low
US$50.59
Mkt. cap
૪.૯૮ અબજ
Avg. vol.
૨૧.૩૧ લાખ
Volume
૧૦.૩૬ લાખ
52-wk high
US$78.48
52-wk low
US$33.03
EPS
-US$6.47
Beta
૧.૩૨
Shares outstanding
૯.૬૪ કરોડ
No. of employees
૩૯૩
News stories
From sources across the web
પ્રોફાઇલ
CRISPR Therapeutics AG is a Swiss–American biotechnology company headquartered in Zug, Switzerland. The company does business as CRISPR Therapeutics, Inc. in the United States. It was one of the first companies formed to utilize the CRISPR gene editing platform to develop medicines for the treatment of various rare and common diseases. The company has approximately 500 employees and has offices in Zug, Switzerland, Boston, Massachusetts, San Francisco, California and London, United Kingdom. Its manufacturing facility in Framingham, Massachusetts won the Facilities of the Year Award award in 2022. The company’s lead program, exagamglogene autotemcel, or exa-cel, was granted regulatory approval by the US Food and Drug Administration in December 2023. Wikipedia
About Crispr Therapeutics AG
CEOસમર્થ કુલકર્ણી
Employees393
Founded2013
HeadquartersZug, Zug, સ્વિટ્ઝર્લૅન્ડ
Sector-
Websitecrisprtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
માર્ચ 2025
જૂન 2025
સપ્ટે 2025
ડિસે 2025
Revenue
8.65 લાખ
8.92 લાખ
8.89 લાખ
8.64 લાખ
Cost of goods sold
13.00 કરોડ
11.50 કરોડ
11.60 કરોડ
13.72 કરોડ
Cost of revenue
13.00 કરોડ
11.50 કરોડ
11.60 કરોડ
13.72 કરોડ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.93 કરોડ
1.89 કરોડ
1.69 કરોડ
1.84 કરોડ
Operating expense
1.93 કરોડ
1.89 કરોડ
1.69 કરોડ
1.84 કરોડ
Total operating expenses
14.93 કરોડ
13.40 કરોડ
13.29 કરોડ
15.56 કરોડ
Operating income
-14.84 કરોડ
-13.31 કરોડ
-13.21 કરોડ
-15.48 કરોડ
Other non operating income
1.35 કરોડ
2.21 કરોડ
2.62 કરોડ
2.48 કરોડ
EBT including unusual items
-13.49 કરોડ
-20.73 કરોડ
-10.58 કરોડ
-13.00 કરોડ
EBT excluding unusual items
-13.49 કરોડ
-11.10 કરોડ
-10.58 કરોડ
-13.00 કરોડ
Income tax expense
11.09 લાખ
12.92 લાખ
6.19 લાખ
6.14 લાખ
Effective tax rate
-0.82%
-0.62%
-0.58%
-0.47%
Other operating expenses
-
-
-
-
Net income
-13.60 કરોડ
-20.85 કરોડ
-10.64 કરોડ
-13.06 કરોડ
Net profit margin
-15,722.08%
-23,379.93%
-11,973.12%
-15,117.25%
Earnings per share
-1.58
-1.29
-1.17
-1.37
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.37 કરોડ
-12.84 કરોડ
-12.76 કરોડ
-14.91 કરોડ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer